Revvity IVISbrite PC3 Red F-luc-GFP Bioluminescent Tumor Cell line (Bioware Brite)

IVISbrite PC3 Red F-luc-GFP Bioluminescent Tumor Cell line

• Organism: Human
• Tissue: Prostate
• Disease: Adenocarcinoma
• Dual Optical Reporters: Red F-luc and GFP

This cell line has very bright bioluminescence, emitting at least 8,000 photons/cell/sec in vitro. The exact number will vary depending on imaging and culturing conditions.

By emitting intensified, longer wavelength light that is significantly brighter than other firefly luciferases, our bioluminescent oncology cell lines allow you to visualize and monitor the growth of deep tissue tumors in vivo. The GFP fusion also allows for fluorescent imaging in vivo or ex vivo.

After the cells are injected into an appropriate mouse model, the optimized Red F-luc luciferase enables more sensitive in vivo optical detection with less tissue attenuation so you can detect tumor development earlier, and monitor tumor growth and metastases in both subcutaneous and orthotopic models.